Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
Humanitas Clinical and Research Center - IRCCS, Via Manzoni 56, 20089 Rozzano (MI), Italy.
Int J Mol Sci. 2020 May 30;21(11):3930. doi: 10.3390/ijms21113930.
Dendritic cells (DCs) constitute a complex network of cell subsets with common functions but also with many divergent aspects. All dendritic cell subsets share the ability to prime T cell response and to undergo a complex trafficking program related to their stage of maturation and function. For these reasons, dendritic cells are implicated in a large variety of both protective and detrimental immune responses, including a crucial role in promoting anti-tumor responses. Although cDC1s are the most potent subset in tumor antigen cross-presentation, they are not sufficient to induce full-strength anti-tumor cytotoxic T cell response and need close interaction and cooperativity with the other dendritic cell subsets, namely cDC2s and pDCs. This review will take into consideration different aspects of DC biology, including the functional role of dendritic cell subsets in both fostering and suppressing tumor growth, the mechanisms underlying their recruitment into the tumor microenvironment, as well as the prognostic value and the potentiality of dendritic cell therapeutic targeting. Understanding the specificity of dendritic cell subsets will allow to gain insights on role of these cells in pathological conditions and to design new selective promising therapeutic approaches.
树突状细胞(DCs)构成了一个具有共同功能但也具有许多不同方面的细胞亚群复杂网络。所有树突状细胞亚群都具有启动 T 细胞反应的能力,并经历与它们的成熟和功能阶段相关的复杂迁移程序。由于这些原因,树突状细胞参与了多种保护性和有害性免疫反应,包括在促进抗肿瘤反应中发挥关键作用。虽然 cDC1s 是肿瘤抗原交叉呈递中最有效的亚群,但它们不足以诱导全强度的抗肿瘤细胞毒性 T 细胞反应,并且需要与其他树突状细胞亚群(即 cDC2s 和 pDCs)密切相互作用和协作。这篇综述将考虑树突状细胞生物学的不同方面,包括树突状细胞亚群在促进和抑制肿瘤生长中的功能作用、它们进入肿瘤微环境的募集机制,以及树突状细胞治疗靶向的预后价值和潜力。了解树突状细胞亚群的特异性将有助于深入了解这些细胞在病理条件下的作用,并设计新的有前途的选择性治疗方法。